Open AccessImmunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial
Author(s) -
Vikrant Saoji,
Nitin Lade,
Rutuja W Gadegone,
Arun Bhat
Publication year - 2016
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/0378-6323.171650
Subject(s) - medicine , purified protein derivative , verruca vulgaris , dermatology , erythema , immunotherapy , surgery , open label , plantar warts , adverse effect , tuberculin , randomized controlled trial , tuberculosis , immunology , immune system , pathology
Warts are known to clear spontaneously with the development of cell-mediated immunity (CMI) to the virus. Purified protein derivative (PPD) of tuberculin bacilli has been used as a non-specific stimulant of CMI to achieve this outcome.